Not at all. Race believed that we only ask the shareholders to fund defined programs and not just chip into a massive slush fund to keep management comfortable. Any unexpected excess funds should be returned to the shareholders.
Unnecessary dilution is never in any shareholders interest. Dilution is a necessary evil that should be as rare and small as possible.
- Forums
- ASX - By Stock
- Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
Not at all. Race believed that we only ask the shareholders to...
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
0.000(0.00%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
$1.48 | $1.50 | $1.46 | $100.3K | 68.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8350 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 958 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8350 | 1.465 |
3 | 16363 | 1.460 |
1 | 13000 | 1.455 |
4 | 48883 | 1.450 |
2 | 25548 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 958 | 1 |
1.485 | 8073 | 2 |
1.490 | 38353 | 1 |
1.500 | 1800 | 1 |
1.525 | 1000 | 1 |
Last trade - 14.40pm 13/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online